Lactic Acid

Lactic Acid

SCHEMBL21145124

CC(O)C(=O)O.CC1(C)COCN1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL21219112 0.89 TSHR (0.39) CYP1A2CYP2D6CYP2C9CYP2C19TSHR
Cadaverine Tartrate SCHEMBL21145241 0.89 TSHR (0.39) CYP1A2CYP2D6CYP2C9CYP2C19TSHR
Oxalic Acid SCHEMBL21145013 0.84 CYP1A2 (0.39) CYP1A2CYP2D6CYP2C9CYP2C19
Acetic Acid SCHEMBL21145074 0.84 CYP1A2 (0.39) CYP1A2CYP2D6CYP2C9CYP2C19
Malic Acid SCHEMBL21219104 0.81 SMN1; SMN2 (0.48) CYP1A2CYP2D6CYP2C9CYP2C19
Malic Acid SCHEMBL21145099 0.81 SMN1; SMN2 (0.48) CYP1A2CYP2D6CYP2C9CYP2C19
Pyruvate SCHEMBL21145152 0.80 CYP1A2 (0.37) CYP1A2CYP2D6CYP2C9CYP2C19
Fumaric Acid SCHEMBL21145115 0.80 TSHR (0.38) TP53CYP1A2CYP2D6CYP2C9CYP2C19
Propionic Acid SCHEMBL21145090 0.78 CYP1A2 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19
Glycolic Acid SCHEMBL21145328 0.78 CYP1A2 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 US disclosed
EP-3518878-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION Henkel AG & Co. KGaA (DE) 2019-08-07 EP disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 TP53 2105/4885CYP1A2 3977/4885CYP2D6 4599/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK TP53 2548/4885CYP1A2 3333/4885CYP2D6 4517/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA TP53 1209/4885CYP1A2 4174/4885CYP2D6 4788/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 TP53 1442/4885CYP1A2 2848/4885CYP2D6 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.